MedPath

Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric Comparative Study

Not Applicable
Completed
Conditions
Chronic Pain
Interventions
Drug: epidural transforaminal injection of magnesuim sulfate
Drug: epidural transforaminal injection of dexmedtemodine
Registration Number
NCT05271721
Lead Sponsor
Minia University
Brief Summary

Transforaminal injection of chronic radicular lower limb injection by either dexmedetomdine or magnesuim sulfate

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Age group. 25-75ys old
  • Both sex.
  • Lumber disc protrusion at one or two segments on MRI.
  • Chronic lumbar radiculer pain for more than 6 weeks refractory to
  • medical treatment for at least 4 weeks. .
  • Positve leg rising test at 30-70 degrees.
Exclusion Criteria
  • Diabetic candidates ( type Ior II).
  • Patient refusal.
  • MRI with disc sequestration.
  • Neurological examination revealed foot drop, neuropathic ulcers
  • Myelopathic or scoliotic patients, .
  • Coagulopathic patients ( cirrhotic patients, on anti-coagulation )

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Magnesuim groupepidural transforaminal injection of magnesuim sulfate. 200 mg Mg sulfate (1ml) plus 4 mg dexamethasone(1ml) plus 40mg lidocaine 2% (2ml)
Dexmedetomidine groupepidural transforaminal injection of dexmedtemodineDexmedetmodine 50mic (0.5ml) ,4 mg dexamethasone (1ml), 40 mg lidocaine 2% (2ml) added to 4ml total volume with sterile saline .
control grouptransforaminal epidural injection of dexamethasoneDexamethasone 4 mg (1ml) plus 40 mg ( 2ml) lidocaine 2% plus 1ml sterile saline
Primary Outcome Measures
NameTimeMethod
pain scoreup to 6 months post-injection

visual analogue pain score. pain value of (0 cm) equals no pain , and value of (10 cm) equals worst pain

Secondary Outcome Measures
NameTimeMethod
functional disabilityup to 6 months post injection

Modified Oswestry Disability Questionnaire....0% to 20%: minimal disability:....21%-40%: moderate disability: 41%-60%: severe disability...61%-80%: crippled

acute complications6 hours post-injection

number of patients developed epidural hematoma by magnetic resonance imaging

Trial Locations

Locations (1)

Minia University

🇪🇬

Minia, Minia University Hospital, Egypt

© Copyright 2025. All Rights Reserved by MedPath